Young-Guk Ko, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. [Operator's Keynote Lecture]
  2. K-pop Study Clinical Outcome
  3. Is EVAR Safe and Durable in Long Term?
  4. ACURATE NEO 2
  5. How Can We Tackle Small Annulus?
  6. How is SAPIEN 3 Valve Design Connected to Clinical Benefit?
  7. Post TAVR PCI
  8. Heavy Calcific Femoral-Popliteal Lesions: Non-atherectomy Strategy and Bailout Stenting Is Still Better.
  9. Optimal Endovascular Treatment with Drug Eluting Stent
  10. Complex Case with Evolut PRO
  11. AAA with Large IIA: Can a Bifurcated Stent Be a Solution?
  12. How to Overcome Limitations of Current Stentgraft
  13. TEVAR for Chronic Dissections-Strategy for Long-term Durability
  14. Introduction of Heli-FX EndoAnchor
  15. SINE After TEVAR: Predictor and Management
  16. Aortoiliac Disease: EVT vs. Surgery
  17. Clinical Application and Use of Rotational Atherectomy System
  18. TAVI in Patients with Difficult Vascular Access
  19. How to Manage Long SFA Lesions
  20. CTO: All or Selective Use?
  21. A Real-World Experience for SFA Treatment
  22. How to Optimize Drug-Coated Balloon in Femoropopliteal Lesions
  23. IN.PACT Global Sub-Analysis on Asian Population
  24. Polyvascular Disease and the Broad Indication of Clopidogrel
  25. The Dream of EVAR Is Not over! EVAR Is Getting Better !
  26. Strategy for Success in Lower Limb - Advanced Technique for Complex BTK Lesion
  27. Subintimal Angioplasty for BTK Occlusions: Standard or Bail-out Approach
  28. Optimal Treatment for Below-the-knee
  29. Evaluation of Intracoronary Thrombus After DES Implantation
  30. Evaluation of Neointima in DES, Quantitative and Qualitative
  31. Improved Technical Success and Miterm Patency with Subintimal Angioplasty (Compared to Intraluminal Angioplasty in Long Femoropopliteal Occlusions)
  32. Introdcution to HT Advance & Whisper ES